Article info

PDF

Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

Authors

  1. Correspondence to Dr Shunsuke Ohnishi; sonishi{at}pop.med.hokudai.ac.jp
View Full Text

Citation

Otagiri S, Ohnishi S, Miura A, et al
Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

Publication history

  • Received March 8, 2018
  • Revised May 7, 2018
  • Accepted May 13, 2018
  • First published May 31, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.